Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079295 | SCV000111165 | benign | not specified | 2013-07-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000468235 | SCV000562875 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620146 | SCV000735693 | benign | Cardiovascular phenotype | 2015-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001675603 | SCV001893277 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001675603 | SCV004563991 | likely benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing |